Regorafenib Versus Placebo to Treat Cholangiocarcinoma

Clinical trial NCT02162914 · UNKNOWN

Trial details

NCT number: NCT02162914
Sponsor: Erasme University Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Cholangiocarcinoma

Start date: 2014-03-14
Primary completion: 2019-03-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.